Welcome to our dedicated page for Alphatec Hldgs SEC filings (Ticker: ATEC), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Searching for the most recent Alphatec Holdings insider trading Form 4 transactions or trying to decode an FDA comment buried deep in a 10-K? Investors often start with a single question—yet end up juggling hundreds of pages about spinal-implant clearances, surgeon partnerships, and R&D milestones. Our SEC filings hub puts every document in context, so you can focus on the implications for spinal-surgery innovation rather than on document hunting.
Each new Alphatec Holdings quarterly earnings report 10-Q filing arrives on Stock Titan within seconds of hitting EDGAR. AI then produces a concise Alphatec Holdings earnings report filing analysis, flags segment revenue shifts, and links directly to tables that matter to spine-device margins. Prefer real-time governance data? Alphatec Holdings Form 4 insider transactions real-time alerts track when surgeon-directors buy or sell shares—perfect for spotting confidence signals before product launches.
Need a high-level view? Start with Alphatec Holdings annual report 10-K simplified summaries that unpack R&D spend, FDA pathways, and competitive positioning. For event-driven traders, Alphatec Holdings 8-K material events explained highlights new product approvals and litigation updates within minutes. If compensation trends guide your valuation models, the Alphatec Holdings proxy statement executive compensation section is mapped to historical pay metrics. And if you just want the facts, "understanding Alphatec Holdings SEC documents with AI" quickly answers natural-language queries like “How much did R&D grow?” while “Alphatec Holdings SEC filings explained simply” gives plain-English context.
From compliance alerts to in-depth analysis, our platform turns Alphatec Holdings executive stock transactions Form 4 data and every other filing type into actionable spinal-tech insight—so you spend your time on decisions, not document searches.
Miles Patrick, who serves as CEO and a director of Alphatec Holdings, Inc. (ATEC), reported a planned sale of 300,000 shares of ATEC common stock on 09/02/2025 under a Rule 10b5-1 trading plan adopted on June 3, 2025. The sales were executed at a weighted average price of $15.73 with individual transaction prices ranging from $15.53 to $15.96. Following the reported disposition, Mr. Patrick beneficially owned 5,564,078 shares directly, plus 10,900 shares held by an IRA and 250,000 shares held indirectly by MOM, LLC. The Form 4 was filed and signed by an attorney-in-fact on behalf of the reporting person.
Alphatec Holdings, Inc. (symbol ATEC) submitted a Form 144 notifying a proposed sale of 300,000 shares of common stock through Morgan Stanley Smith Barney LLC on the NASDAQ, with an aggregate market value of $4,770,000.00. The reported shares were acquired as Restricted Stock Units on 10/02/2020 and the acquisition and payment date is also listed as 10/02/2020. The filing shows 147,983,775 shares outstanding, and an approximate date of sale of 09/02/2025. The filer states there were no securities sold in the past three months for the account and includes the standard representation that the selling person does not possess undisclosed material adverse information.
Alphatec Holdings, Inc. (ATEC) insider sale reported by Chief Operating Officer Lish Scott. The Form 4 shows that on 08/21/2025 the reporting person sold 6,323 shares of Alphatec common stock under a Rule 10b5-1 trading plan adopted March 14, 2025, at a weighted average price of $16.01 per share. After the sale the reporting person beneficially owned 658,707 shares. The filer indicates the price range for the multiple transactions was $16.00 to $16.02 and that full allocation details are available on request. The form was signed by an attorney-in-fact on behalf of the reporting person.
Alphatec Holdings insider sale under 10b5-1 plan. Lish Scott, Chief Operating Officer of Alphatec Holdings, Inc. (ATEC), reported a sale of 9,302 shares of common stock on 08/13/2025 at a price of $16.00 per share. After this transaction the reporting person beneficially owned 665,030 shares, held directly. The filing states the sales were executed pursuant to a Rule 10b5-1 trading plan adopted on March 14, 2025, indicating the transactions were prearranged rather than opportunistic trades. The Form 4 was submitted through an attorney-in-fact signature.
Miles Patrick, CEO and Director of Alphatec Holdings, Inc. (ATEC), reported an insider transaction on 08/14/2025. The filing shows a sale of 10,000 common shares and discloses beneficial ownership following the transaction of 5,864,078 shares directly, plus 10,900 shares held in an IRA and 250,000 shares held indirectly by MOM, LLC. The Form 4 is signed by an attorney-in-fact on behalf of the reporting person.
Alphatec Holdings, Inc. filed a Form 144 reporting a proposed sale of 15,625 common shares through Morgan Stanley Smith Barney LLC, with an aggregate market value of $245,625. The sale is listed for execution approximately on 08/13/2025 on NASDAQ, against a total of 147,983,775 shares outstanding.
The securities were acquired on 02/24/2023 as 7,011 Performance Stock Units and 8,614 Restricted Stock Units, which together equal the 15,625 shares proposed for sale. The filing also discloses prior sales in the past three months totaling 152,688 shares for gross proceeds of approximately $1,971,447.50, several of which are identified as 10b5-1 plan transactions. The filer attests to no undisclosed material adverse information in connection with the notice.
Alphatec Holdings (ATEC) – Form 4: EVP, People & Culture Craig E. Hunsaker disclosed two open-market sales executed under a pre-arranged Rule 10b5-1 plan adopted 5-Mar-2025.
- 08-Aug-2025: Sold 50,000 common shares at a weighted avg. price of $15.00.
- 09-Aug-2025: Sold 10,876 common shares at $15.33.
After the transactions, Hunsaker directly owns 1,389,142 ATEC shares, down from roughly 1.45 million. The sales represent about 4.2 % of his direct stake.
No derivative security activity was reported. The filing contains no new operational or financial guidance; it solely documents the insider’s change in beneficial ownership.
Form 144 filing for Alphatec Holdings, Inc. (ATEC)
The filing discloses a proposed sale of 18,092 common shares with an aggregate market value of $269,688.68, scheduled for 08/05/2025 on NASDAQ through Morgan Stanley Smith Barney LLC. The securities were acquired on 08/05/2025 as restricted stock vesting under a registered plan and payment is listed as compensation. The filing also reports prior sales by the same person in the past three months: 12,878 shares on 08/01/2025 (gross proceeds $154,016.00) and 1,500 shares on 07/10/2025 (gross proceeds $17,936.00).
Administrative note: Filer identification fields (CIK/CCC/name) are not populated in the provided text.
FAQ
What is the current stock price of Alphatec Hldgs (ATEC)?
What is the market cap of Alphatec Hldgs (ATEC)?
